Co-innovation advances medtech
The global pandemic may have felt like a once-in-a-generation event, but the likelihood of further COVID-19-scale pandemics could triple in the coming decades – exacerbated by climate change.
The scale and complexity of this challenge calls for a new breed of problem solving that’s optimised for speed, scale, and borderless collaboration. We have a far greater chance at innovating digital health solutions at scale when knowledge, capabilities, and diverse industries are connected – by data and a common goal – as part of an innovation ecosystem.
The COVID-19 response was a huge step forward in this direction, with unprecedented knowledge sharing and data-empowered co-innovation between diverse parties – across science, technology, government, civil society, and beyond.
For the NHS, the progress made towards becoming a cloud- and data-enabled organisation will be essential for playing an active and valuable role in evolving medical ecosystems.
Together with Zühlke, the organisation was able to transform anonymised test and trace app data into valuable, actionable, and democratised knowledge. This data capability will be essential for helping to co-create tomorrow’s medical solutions and push the boundaries of public health innovation.
Read on to discover how the NHS COVID-19 app – the first certified mobile medical device in the UK – advanced digital health and showed the value of collaboration and co-innovation.